CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- S-3 Offering Registration Statement
- 4 Grant or award CHIEF OPERATING OFFICER acquired 16,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 16,000 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 44,000 shares (grant or award)
- 4 Grant or award GENERAL COUNSEL acquired 14,500 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 16,000 shares (grant or award)
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Exit or restructuring costs
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- ARS Other Annual Report to Security Holders
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,081 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,229 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 3,073 shares (to pay taxes)
Page 10 of 32 · 633 filings